Hinge Health (NYSE:HNGE) Shares Cross Below 50 Day Moving Average – Here’s Why

Hinge Health Inc. (NYSE:HNGE – Get Free Report) shares passed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $106.02 and traded as low as $103.12. Hinge Health shares last traded at $105.65, with a volume of 1,649,319 shares trading hands.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on HNGE shares. Citigroup restated an “outperform” rating on shares of Hinge Health in a report on Monday, July 27th. Wall Street Zen raised shares of Hinge Health from a “hold” rating to a “buy” rating in a research report on Saturday, November 7th. Morgan Stanley raised their target price on shares of Hinge Health from $117.00 to $131.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 3rd. Robert W. Baird lifted their target price on shares of Hinge Health from $85.00 to $90.00 and gave the company a “neutral” rating in a research note on Tuesday, September 22nd. Finally, Stifel Nicolaus boosted their price target on shares of Hinge Health from $130.00 to $135.00 and gave the company a “buy” rating in a research report on Tuesday, November 3rd. Two research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $118.93.

Read Our Latest Research Report on HNGE

Hinge Health Stock Performance

The stock’s 50-day moving average price is $106.02 and its two-hundred day moving average price is $72.75. The stock has a market capitalization of $8.59 billion, a PE ratio of 53.90, a P/E/G ratio of 1.49 and a beta of 1.19.

Hinge Health (NYSE:HNGE – Get Free Report) last issued its quarterly earnings results on Monday, November 2nd. The company reported $0.71 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.44. The firm had revenue of $234.97 million during the quarter. Hinge Health had a return on equity of 66.96% and a net margin of 21.02%. Hinge Health’s revenue was up 52.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.02) earnings per share. On average, analysts predict that Hinge Health Inc. will post 1.56 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO James Budge sold 35,907 shares of the company’s stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $121.62, for a total transaction of $4,367,009.34. Following the transaction, the chief financial officer directly owned 256,207 shares of the company’s stock, valued at $31,159,895.34. This represents a 12.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President James Pursley sold 33,000 shares of the stock in a transaction on Monday, September 21st. The shares were sold at an average price of $94.14, for a total value of $3,106,620.00. Following the sale, the president directly owned 666,909 shares in the company, valued at $62,782,813.26. This trade represents a 4.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,226,288 shares of company stock worth $121,470,244 over the last three months. 18.92% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Hinge Health

Several hedge funds and other institutional investors have recently modified their holdings of HNGE. 11.2 Capital Management LLC purchased a new position in Hinge Health during the second quarter valued at approximately $204,566,531. Assenagon Asset Management S.A. lifted its stake in shares of Hinge Health by 2,141.9% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,854,922 shares of the company’s stock valued at $180,373,000 after buying an additional 1,772,182 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in Hinge Health by 68.1% in the 3rd quarter. Goldman Sachs Group Inc. now owns 1,699,677 shares of the company’s stock worth $165,277,000 after buying an additional 688,421 shares during the period. Wellington Management Group LLP boosted its holdings in Hinge Health by 169.7% in the 2nd quarter. Wellington Management Group LLP now owns 1,205,584 shares of the company’s stock worth $100,063,000 after buying an additional 758,594 shares during the period. Finally, Voya Investment Management LLC increased its stake in Hinge Health by 53.8% in the 3rd quarter. Voya Investment Management LLC now owns 1,196,896 shares of the company’s stock worth $116,386,000 after buying an additional 418,728 shares in the last quarter.

About Hinge Health

(Get Free Report)

Hinge Health is a digital health company focused on musculoskeletal care, including support for people with back, joint and muscle pain. Its services are designed to help members manage conditions through personalized, technology-enabled care. The company’s offerings include app-based exercise therapy, education and behavioral support, along with access to clinical care teams. Hinge Health also uses wearable motion sensors in some programs to guide and track exercises. Founded in 2015, Hinge Health primarily provides its services through employers and health plans.

See Also

Receive News & Ratings for Hinge Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hinge Health and related companies with MarketBeat.com's FREE daily email newsletter.